Exegenesis Bio, a leading genetic medicines company, unveiled encouraging clinical efficacy and safety results for their EXG001-307 gene therapy...
At the 2024 SCOPE Summit, Demetris Zambas, VP and Global Head of Data Monitoring and Management at Pfizer explored...
The industry loves to celebrate synthetic data as a privacy solution—but where’s the real impact? Let’s be clear: privacy...
Cross-border data transfers are a critical yet complex aspect in clinical trials. With global collaborations becoming the norm, personal...
In the dynamic world of clinical trials, Yunu is revolutionizing imaging services with cutting-edge technology and strategic partnerships. Jeffrey...
In the rapidly evolving world of clinical trial technology, Debi Willis, CEO of MyPatientLink, is leading the charge in...
Lantern Pharma, through its subsidiary Starlight Therapeutics, revealed preclinical data and Phase 1b trial designs for LP-184 (STAR-001 for...
In a groundbreaking presentation at SCOPE Europe 2024, Susannah Finney, Clinical Operations Lead and Product Owner at Roche, UK,...
Neurogene Inc. announced positive interim clinical data from its Phase 1/2 open-label trial of NGN-401 gene therapy for Rett...
The landscape of clinical trials is experiencing a paradigm shift with the integration of Real-World Data (RWD). Traditionally conducted...
